Shopping Cart
- Remove All
- Your shopping cart is currently empty
Sampatrilat is an effecive and orally active vasopeptidase inhibitor of ACE and neutral endopeptidase. Sampatrilat inhibits C-domain ACE (Ki=13.8 nM) 12.4-fold more potent than that for the N-domain (Ki=171.9 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,820 | 8-10 weeks | |
50 mg | $2,380 | 8-10 weeks | |
100 mg | $3,100 | 8-10 weeks |
Description | Sampatrilat is an effecive and orally active vasopeptidase inhibitor of ACE and neutral endopeptidase. Sampatrilat inhibits C-domain ACE (Ki=13.8 nM) 12.4-fold more potent than that for the N-domain (Ki=171.9 nM). |
Targets&IC50 | CACE:(ki)13.8 nM, nACE:171.9 nM(ki) |
In vivo | Sampatrilat (p.o.; 30 mg/kg; once a day; 5 weeks) decreases the mortality of the rats with CAL (20% versus 57% for untreated rats) and increase in the survival rate and improvement of the hemodynamic function of the rats with CAL [2]. |
Alias | UK-81252 |
Molecular Weight | 584.68 |
Formula | C26H40N4O9S |
Cas No. | 129981-36-8 |
Relative Density. | 1.343g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.